The programme seeks to enhance the production of new drugs through a powerful research programme in Chemical Biology that will allow the creation of a chemical biology hub in Barcelona.
By supporting the appointment of two new Junior Group Leaders, the programme has facilitated the setup of two new research groups, one at IRB Barcelona and the other at IBEC.
IRB Barcelona's commitment to talented young female scientists takes shape with the appointment of Dr. Cristina Mayor-Ruiz, who will be leading a scientific project with wide applications in patients devoted to the innovative technique of targeted protein degradation.
Funded under the Science with and for Society Programme of Horizon 2020, ENABLECARES will deliver high-level training in open science, entrepreneurship and other relevant transferable skills to young scientists in Europe.
Building on the expertise of IRB Barcelona's Innovation Department and Radboud University on entrepreneurship and Open Science, ENABLECARES will implement two training curricula in these subjects (nodes) at all four partners through co-creation and Train-the-Trainers strategies.
The ICREA Acadèmia Award allows university professors to prioritise their dedication to research for 5 years.
The Cell Signaling laboratory, headed by Dr. Eulàlia de Nadal and Dr. Francesc Posas, studies cell adaptation response to stress.
This day promotes equal access to and full participation in science for women and girls.
Outreach activities are held focused on making the work of female researchers visible and encouraging girls to have these role models.
In the context of this day, IRB Barcelona shares an example of the visibility of the women scientists: girls and boys at the Pau Casals de Gracia school (Barcelona) have named their class after the researcher Núria López-Bigas.
The 5-year research project involves 14 organisations in seven EU countries and is funded by €15 M from the EU.
The Genome Data Science lab, led by ICREA researcher Fran Supek, will analyse the evolution of ovarian tumours to develop computational models for predicting treatment resistance.
Key for biomedical research, this new piece of unique and exclusive technology allows non-invasive visualisation of organ physiology and alterations.
More than 6,300 people have participated in the #MetastasisChallenge, which aims to raise €5 million to support research into metastasis—the main cause of cancer deaths.
Xavier Salvatella's laboratory at IRB Barcelona receives €180,000 to develop new drugs against prostate cancer.
The AECC Innova projects are focused on technology transfer and aim to get research results to the patient faster.
The financing round is led by Alta Life Sciences Spain I FCR, a vehicle managed by Altamar Private Equity SGIIC. Existing investors including Institut Català de Finances (ICF) have also participated in the financing.
Inbiomotion is in advanced stage of development of a single gene-based test for predicting response to bisphosphonates in breast cancer adjuvant setting and prevent metastasis.
The capital increase is intended to complete regulatory development to commercialize next year.
Inbiomotion’s product addresses a significant companion diagnostics market globally.
The State Research Agency grants this competitive accreditation to recognise, promote and fund scientific research of excellence in Spanish institutions of great international relevance.
Only two research centres in the field of biomedicine, namely the Spanish National Cancer Research Centre (CNIO) and the Institute for Research in Biomedicine (IRB Barcelona), have achieved three consecutive "Severo Ochoa" Centre of Excellence accreditations since this distinction was launched in 2011.
Manuel Serrano, Head of the Cell Plasticity and Senescence lab at IRB Barcelona, has been recognised for his important contributions to the field of cell biology.
Each endowed with €150,000, the Leopold Griffuel Awards are given yearly to two researchers whose exceptional work has accelerated the fight against cancer.